Zybrestat fosbretabulin: Additional Phase II data

Additional data from the open-label, U.S. Phase II GOG 186I trial in 107 patients with platinum-sensitive and -resistant recurrent or persistent epithelial ovarian, fallopian tube or primary peritonea...